ASTRAZENBSEAstraZeneca Pharma India LtdMediumNeutral
Announced Tue, 12 May · 18:57 IST

This is in reference to the intimation submitted to the exchange at 1:05 PM under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding ....

ASTRAZEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.9%1-day move
₹8399.50
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.9+0.6+1.8+3.6+2.3+2.1+1.7+0.1-1.5
Up moveDown movePending
AI summary

AstraZeneca Pharma India Ltd's shareholders have approved the relocation of the company's registered office from the State of Karnataka to the State of Maharashtra. The approval was granted through a special resolution passed via postal ballot using remote e-voting, with results declared on May 12, 2026. This change will require an amendment to the 2nd Clause of the company's Memorandum of Association and is subject to receiving necessary regulatory approvals under the Companies Act, 2013 and applicable rules.

Likely market impact

This is an administrative relocation that may offer operational or regulatory advantages given Maharashtra's business ecosystem, but it does not directly affect the company's business operations or financial performance in the near term.